Tristar Wellness Solutions, Inc. (TWSI)

[sweet crude]

Ask - 3000 @ .24 ($720)

need some bids above .15

TWSI

[sweet crude]

TWSI has FDA approval in both US and China

...that's major, and should justify $1.00 alone

[sweet crude]

i expect run to $1.00+

this has all the parts for it...plus CEO has warrants @ $1.00...its heain there and higher

[Stock Rockstar]

Get ready, guys. This is running to .40 imo!

[sweet crude]

TWSI chart

screaming breakout here

[VisionTrade]

Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device.

Thanks to HemCon Medical, "TWSI" is about leave pennyland. We will see major moves here.

[sweet crude]

$1.00 is very possible here

...with US and China FDA approval, those alone could justify TWSI trading $1.00+

[Stock Rockstar]

TWSI breaking out! I'm not leaving till at least $1.00

[sweet crude]

3000 @ .225 ask...then BREAKOUT!!!

http://www.otcmarkets.com/stock/twsi/quote

TWSI

[sweet crude]

5000 @ .17...then .22 is up

http://www.otcmarkets.com/stock/twsi/quote

TWSI

[sweet crude]

ask .17, ready to run

last chance, then .20s which on chart is a full breakout

[VisionTrade]

Everyone trying to get cheap shares before the run above 1.00.

Remember "TWSI" has a super low float, so it will not take much to push this stock over the 1.00 mark on the first day of the run.

[sweet crude]

TWSI has US and China FDA approval

that alone should make stock worth $1.00 per share

[sweet crude]

.14 x .17.....breakout coming

once this hits a few radars, or gets a couple key traders in this...blast off!

[Stock Rockstar]

Not bad at all, they're steadily moving back, closer to their rightful place. Should AT LEAST be a .4 company!

[VisionTrade]

Looks like the MM's are getting in on "TWSI". That means we are about to see a run.

[sweet crude]

NITE on bid @ .12....nice

http://www.otcmarkets.com/stock/TWSI/quote

[sweet crude]

.12 x .175

...after .175 we got .25 (breakout)

[madcabbage]

Tristar web site is all screwed up. Really needs work.

[sweet crude]

.175, then .29

TWSI

[VisionTrade]

Big moves about to happen. Current news already posted and 1st Qtr. Results about to be posted will run "TWSI" up the chart.

[sweet crude]

NIH grant = 50% of TWSI market cap

we got to get this story on some traders boards...that NIH grant is half the value of company currently, insane!!!

TWSI being funded by US govt...omg!

[Global Source]

Below is the current news I was able to pull on "TWSI". I agree this is excellent news.

PORTLAND, Ore. , May 6, 2015 /PRNewswire/ -- TriStar Wellness Solutions(R), Inc. a health and wellness company that targets opportunities in the advanced wound care marketplace, announced today that its Portland, Oregon based wholly owned independent subsidiary HemCon Medical Technologies, Inc. (HemCon) has been awarded funding from the National Institutes of Health (NIH) to develop a novel chitosan endoluminal hemostatic dressing that is able to be delivered by a catheter to control and prevent prostatic bleeding during prostatic surgery such as transurethral resection of the prostate (TURP). Oregon Health & Science University (OHSU) will work with HemCon as a subcontractor on development of the dressing.

[VisionTrade]

Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device

This very sweet NEWS!!!

[sweet crude]

China FDA approval = $1.00

getting approval from China's FDA to sell in their country should put TWSI at $1.00 just on that event alone

[sweet crude]

NASDAQ:PINC + China = $$$$$

TWSI has purchase order with NASDAQ listed Premier, Inc (PINC)...which is hitting a new 52 week high...i expect to see some of that in Q1 results..

....also they are already selling into China, sales happening now....next few earnings and this wil be pushing $1.00, just got to get more people aware of this solid story

[VisionTrade]

"TWSI" hitting 52-week low and also being a supper low float, plus positive 1st Qtr. Sales about to be released. "TWSI" is going to leap up the chart.

[sweet crude]

Q1 earnings expected soon

Im expecting solid numbers, and hoping for some guidance for rest of 2015, or current quarter. TWSI says they expect to become profitable in 2015...bring it!!

TWSI

[VisionTrade]

The China deals and the super low float will make this stock fly.

[sweet crude]

one MM left @ .10

TWSI

[madcabbage]

This low floater looks interesting especially with the approval and sales in China. This should be getting alot more attention than it is at the moment.

[sweet crude]

.10 x .13 (26,100 left on ask)

then asking .18
http://www.otcmarkets.com/stock/TWSI/quote

TWSI

[Stock Rockstar]

5000 @ .18...then .25

level 2 looks super thin from .18 to .35
http://www.otcmarkets.com/stock/twsi/quote

trying to free up some cash from other trades to grab anything down here

[sweet crude]

Real Time Level 2 now on OTC Markets

TWSI now has real time level 2 on OTC Markets...i love this as it now shows real time bid/ask, but also size on offer, and how thing next ask is.

Real Time Level 2
http://www.otcmarkets.com/stock/twsi/quote


Look how thin TWSI is till .40....go baby!!!

[Stock Rockstar]

It's quiet here, but TWSI is holding up well

[Global Source]

I agree "TWSI" is about to breakout. Tristar Wellness Solutions, Inc. (TWSI) has been posting updates on the continuous growth progress of HemCon Medical Technologies. The China Food and Drug Administration (CFDA) approval(wound care market $1.2 Billion) will be huge for "TWSI".

[sweet crude]

Asking .25.....breakout coming

Any hit at .25 would push price above 200 day trendline...breakout coming
http://www.otcmarkets.com/stock/TWSI/news

[sweet crude]

TWSI saved US soldiers lives

HemCon's original medical device product, the HemCon Bandage, was developed in partnership with the U.S. Army. Between 2003 and 2008, the bandage was the standard issue hemorrhage control bandage for all U.S. Army soldiers, and is credited with saving many lives on the battlefield.

[Global Source]

EXTREMELY GREAT NEWS FOR TWSI JUST RELEASED TODAY. HemCon Medical Technologies, Inc. owned by "TWSI" has received regulatory approval from the China Food and Drug Administration (CFDA). The wound care market in China is estimated at $1.2 Billion. This is major news for an American Medical Company to receive CFDA approvalfrom China.

[VisionTrade]

WOW!!! TWSI with this type of news is going to jump multiple dollars.

[sweet crude]

TWSI gets China approval ...kaboom!!!!

holy smokes this is huge!!!!!

[Stock Rockstar]

NEWSSSS!!

HemCon Medical Technologies Launches into Chinese Market

PORTLAND, Ore., April 7, 2015 /PRNewswire/ -- TriStar Wellness Solutions, Inc. (TWSI), a health and wellness company that targets opportunities in the advanced wound care marketplace, through its subsidiary, HemCon Medical Technologies, Inc has received regulatory approval from the China Food and Drug Administration (CFDA) to market and sell products into China. HemCon has commercially entered the market this month by accepting an order through a distributor on the mainland. HemCon's launch into the Chinese market will include its full portfolio of wound care solutions which are protected by patents both in China and throughout the world. Currently the wound care market in China is estimated at $1.2 billion.

Photo - http://photos.prnewswire.com/prnh/20150406/196695

Photo - http://photos.prnewswire.com/prnh/20150406/196696

HemCon has prior experience in the pan-Asian market having successfully established a wound care product line in Japan with their partner ZERIA Pharmaceutical.

Michael Wax, President and CEO said, "With our initial Chinese order in hand, combined with the Chinese government's approval for import of our dressings, we are looking ahead to building a robust business in a rapidly growing market. We have expectations to participate in the fast growing pan-Asian health care industry and specifically the increasing demand for wound care in China."

About HemCon Medical Technologies

HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.

About TriStar Wellness Solutions

TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets opportunities in the advanced wound care marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions.

Forward-Looking Statement

This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.

Contact:
Stephanie Wiegman
Tel: [phone]
Email

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hemcon-medical-technologies-launches-into-chinese-market-300061723.html

[sweet crude]

Earnings could come this week

Im shocked this doesnt trade more active as it should...this is a real deal company with good revenues, and going profitable

[Stock Rockstar]

More $TWSI NEWS!!

HemCon Medical Technologies, Inc. Receives 2015 Best of Portland Award
PR Newswire HemCon Medical Technologies, Inc.
?
PORTLAND, Ore., March 24, 2015 /PRNewswire/ -- HemCon Medical Technologies, Inc ("HemCon"), a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (TWSI) and a leading developer and marketer of advanced wound care products, today announced it received the 2015 Best of Portland Award in the Bandages & Dressing category by the Portland Award Program.

Logo - http://photos.prnewswire.com/prnh/20150323/183928LOGO
Logo - http://photos.prnewswire.com/prnh/20150323/183927LOGO

Each year, the Portland Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and our community. These exceptional companies help make the Portland area a great place to live, work and play.

Various sources of information were gathered and analyzed to choose the winners in each category. The 2015 Portland Award Program focuses on quality, not quantity. Winners are determined based on the information gathered both internally by the Portland Award Program and data provided by third parties.

Michael Wax, CEO of HemCon, said, "We are honored that our community here in Portland has chosen to recognize our company. It is a credit to all the employees here in Portland and our employees in the EU who have worked so diligently to produce superior medical devices."

About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.

About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets opportunities in the advanced wound care marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions.

About Portland Award Program
The Portland Award Program is an annual awards program honoring the achievements and accomplishments of local businesses throughout the Portland area. Recognition is given to those companies that have shown the ability to use their best practices and implemented programs to generate competitive advantages and long-term value.

The Portland Award Program was established to recognize the best of local businesses in our community. Our organization works exclusively with local business owners, trade groups, professional associations and other business advertising and marketing groups. Our mission is to recognize the small business community's contributions to the U.S. economy

[Global Source]

NEWS Yesterday!!

PORTLAND, Ore. , March 17, 2015 /PRNewswire/ -- HemCon Medical Technologies, Inc. ("HemCon"), a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. and a leading developer and marketer of advanced wound care products, announced today that HemCon has joined aptitude LLC the healthcare industry's first direct contracting market. Today, aptitude has over 1,000 hospitals that benefit from reducing the online platform that reduces the contract cycle time by 50% by automating key components of the process. HemCon has added its full product line to aptitude and hopes to introduce new customers by using the user friendly interface and quick turn around on contracts. HemCon plans to continue to grow its portfolio online, which will be beneficial to all current and prospective HemCon customers. Adding an additional way to take its products to market supports HemCon's continuing expansion into the hospital market.

Logo - http://photos.prnewswire.com/prnh/20150316/181954LOGO
Logo - http://photos.prnewswire.com/prnh/20150316/181955LOGO

Michael Wax , CEO of HemCon, remarked, "We are pleased to join aptitude and participate in their innovative cost reduction supply model. The agreement to offer our products to hospitals through aptitude was timely and fluid. We are confident that this fast growing technology based platform will continue to grow rapidly and help add to our market reach."

"We are excited that HemCon has decided to join the aptitude market place. We anticipate that our healthcare providers will be very excited to build new and expand existing committed contracts relationships with HemCon through aptitude's innovative market approach," said Troy Kirchenbauer, General Manager of aptitude LLC.

About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.

About TriStar Wellness Solutions(TWSI)
TriStar Wellness Solutions®, Inc. is a health and wellness company that targets opportunities in the advanced wound care marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions.

About aptitude:
As healthcare's direct contracting market, aptitude LLC is meeting the evolving demands of today's healthcare organizations. Hospitals and suppliers are intrigued by how aptitude re-imagines the contracting model and provides the driving force for a more logical market in which both parties can achieve mutually beneficial, committed purchasing relationships for a better value proposition for both. Today, hospitals and suppliers have a combined $15 billion in purchasing power and are experiencing an average savings of 10 to 15 percent.

This low float stock is going to a nice run.

[sweet crude]

News: TWSI scores hospital contract

PORTLAND, Ore. -- HemCon Medical Technologies, Inc. ("HemCon"), a wholly owned subsidiary of TriStar Wellness Solutions, Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced wound care products, announced today that HemCon has joined aptitude LLC the healthcare industry's first direct contracting market.

Today, aptitude has over 1,000 hospitals that benefit from reducing the online platform that reduces the contract cycle time by 50% by automating key components of the process. HemCon has added its full product line to aptitude and hopes to introduce new customers by using the user friendly interface and quick turn around on contracts. HemCon plans to continue to grow its portfolio online, which will be beneficial to all current and prospective HemCon customers. Adding an additional way to take its products to market supports HemCon's continuing expansion into the hospital market.

Michael Wax, CEO of HemCon, remarked, "We are pleased to join aptitude and participate in their innovative cost reduction supply model. The agreement to offer our products to hospitals through aptitude was timely and fluid. We are confident that this fast growing technology based platform will continue to grow rapidly and help add to our market reach."

"We are excited that HemCon has decided to join the aptitude market place. We anticipate that our healthcare providers will be very excited to build new and expand existing committed contracts relationships with HemCon through aptitude's innovative market approach," said Troy Kirchenbauer, General Manager of aptitude LLC.

About HemCon Medical Technologies HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.

About TriStar Wellness Solutions TriStar Wellness Solutions?, Inc. (OTCQB:TWSI) is a health and wellness company that targets opportunities in the advanced wound care marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions.

About aptitude: As healthcare's direct contracting market, aptitude LLC is meeting the evolving demands of today's healthcare organizations. Hospitals and suppliers are intrigued by how aptitude re-imagines the contracting model and provides the driving force for a more logical market in which both parties can achieve mutually beneficial, committed purchasing relationships for a better value proposition for both. Today, hospitals and suppliers have a combined $15 billion in purchasing power and are experiencing an average savings of 10 to 15 percent.

Forward-Looking Statement This press release for TriStar Wellness Solutions?, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished

[VisionTrade]

Last form submitted by the "TWSI" looks like we are being setup for a run once financials are released later this month.

[sweet crude]

not much left at .25, then kaboom

im hoping for some guidance for 2015 cause gonna go profitable

TWSI

[Global Source]

The 2014 earnings on TWSI look very promising. The low float on on TWSI with a positive earnings report will moon shot this stock. Bought a few shares just not to miss the run on this one.

[VisionTrade]

"TWSI" breakout could run over 1000% on financials alone. Report due this month.